Oxidative stress parameters in diabetic rats submitted to forced swimming test: the clonazepam effect

Brain Research

Volumn 1154, Issue 1, 2007, Pages 137-143

  Haeser, Alexsandro da Silva ^a   Sitta, Angela ^a,b   Barschak, Alethéa Gatto ^a,b   Deon, Marion ^a,b   Barden, Amanda Thomas ^a   Schmitt, Graziela Oliveira ^a,b   Landgraff, Sharon ^a,b   Gomez, Rosane ^c   Barros, Helena M T ^c   Vargas, Carmen Regla ^a,b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

Author keywords

Clonazepam; Depression; Diabetes mellitus; Free radicals; Lipoperoxidation; Oxidative stress

Indexed keywords

CATALASE; CLONAZEPAM; FREE RADICAL; STREPTOZOCIN; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD SAMPLING; BRAIN CORTEX; CONTROLLED STUDY; CORPUS STRIATUM; DEPRESSION; DIABETES MELLITUS; DRUG EFFECT; FORCED SWIMMING TEST; HIPPOCAMPUS; LIPID PEROXIDATION; MALE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; STATISTICAL ANALYSIS; STREPTOZOCIN DIABETES; WISTAR RAT;

ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; CATALASE; CLONAZEPAM; DEPRESSION; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; ERYTHROCYTES; GABA MODULATORS; MALE; OXIDATIVE STRESS; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE; SWIMMING; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

EID: 34249822777     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2007.03.088     Document Type: Article

References (40)

1. Aebi H. Catalase in vitro. Methods Enzymol. 105 (1984) 121-126
2. Baynes J.W. Role of oxidative stress in development of complications in diabetes. Diabetes 40 (1991) 405-412
3. Bellush L.L., Reid S.G., and North D. The functional significance of biochemical alterations in streptozotocin-induced diabetes. Physiol. Behav. 50 (1991) 973-981
4. Bem-Menachem E., Kyllerman R., and Markleind S. Superoxide dismutase and glutathione peroxidase function in progressive myoclonus epilepsies. Epilepsy Res. 40 (2000) 33-39
5. Biessels G.J., Van Der Heide L.P., Kamal A., Bleys R.L., and Gispen W.H. Aging and diabetes: implications for brain function. Eur. J. Pharmacol. 441 (2002) 1-14
6. Ceriello A. Oxidative stress and diabetes-associated complications. Endocr. Pract. 12 Suppl 1 (2006) 60-62
7. Ceriello A., Morocutti A., Mercuri F., Quagliaro L., Moro M., Damante G., and Viberti G.C. Defective intracellular antioxidant enzyme production in type 1 diabetic patients with nephropathy. Diabetes 49 (2000) 2170-2177
8. Chevassus H., Mourand I., Molinier N., Lacarelle B., Brun J.F., and Petit P. Assessment of single-dose benzodiazepines on insulin secretion, insulin sensitivity and glucose effectiveness in healthy volunteers: a double-bind, placebo-controlled, randomized cross-over trial. BMC Clin. Pharmacol. 4 (2004)
9. Duarte A.I., Santos M.S., Seica R., and de Oliveira C.R. Insulin affects synaptosomal GABA and glutamate transport under oxidative stress conditions. Brain Res. 977 1 (2003) 23-30
10. Duarte A.I., Santos M.S., Seica R., and de Oliveira C.R. Oxidative stress affects synaptosomal gamma-aminobutyric acid and glutamate transport in diabetic rats: the role of insuline. Diabetes 53 8 (2004) 2110-2116
11. Esterbauer H., and Cheeseman K.H. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol. 186 (1990) 407-421
12. Gavard J.A., Lustman P.J., and Clouse R.E. Prevalence of depression in adults with diabetes. Diabetes Care 16 (1993) 1167-1178
13. Gomez R., and Barros H.M.T. Ethopharmacology of the antidepressant effect of clonazepam in diabetic rats. Pharmacol. Biochem. Behav. 66 (2000) 329-335
14. Gomez R., Asnis N., Tannhauser S.L., and Barros H.M. GABA agonists differentially modify blood glucose levels of diabetic rats. Jpn. J. Pharmacol. 80 4 (1999) 327-331
15. Guidotti A., Auta J., Davis J.M., Dong E., Grayson D.R., Veldic M., Zhang X., and Costa E. GABAergic dysfunction in schizophrenia: new treatment strategies on the horizon. Psychopharmacology 180 2 (2005) 191-205
16. Guyot L.L., Diaz F.G., O'regan M.H., Song D., and Phillis J.W. The effect of streptozotocin-induced diabetes on the release of excitotoxic and other amino acids from the ischemic rat cerebral cortex. Neurosurgery 48 (2001) 385-391
17. Halliwell B. Free radicals, antioxidants, and human disease: curiosity, cause or consequence?. Lancet 344 (1994) 721-724
18. Hilakivi-Clarke L.A., Wozniak K.M., Durcan M.J., and Linnoila M. Behavior of streptozotocin-diabetic mice in tests of exploration, locomotion, anxiety, depression and aggression. Physiol. Behav. 48 (1990) 429-433
19. Imaeda V., Aoki T., Kondo Y., Hori M., Ogata M., Obayashi H., Hasegawa G., Nakamura N., Tokuda K., Nishino H., Yoshikawa T., and Kondo M. Protective effects of fluvastatin against reactive oxygen species induced DNA damage and mutagenesis. Free Radic. Res. 34 1 (2001) 33-44
20. Kocak G., Aktan F., Canbolat O., Ozogul C., Elbeg S., Yildizoglu-Ari N., and Karau C. Alpha-lipoic acid treatment ameliorates metabolic parameters, blood pressure, vascular reactivity and morphology of vessels already damaged by streptozotocin-diabetes. Diabetes Nutr. Metab. 13 6 (2000) 308-318
21. Li Z.G., and Sima A. C-peptide and central nervous system complication in diabetes. Exp. Diabesity Res. 5 1 (2004) 79-90
22. Lissi E., Pascual C., and Del Castillo M. Luminol luminescence induced by 2,2′-azo-bis-(2-amidinopropane) thermolysis. Free Radic. Res. Commun. 17 (1992) 299-311
23. Lorenc-Koci E., Sokolowska M., Kwiecién I., and Wlodek L. Treatment with 1,2,3,4-tetrahydroisoquinolone affects the levels of nitric oxide, S-nitrosothiols, glutathione and the enzymatic activity of γ-glutamyl transpeptidase in the dopaminergic structures of rat brain. Brain Res. 1049 (2005) 133-146
24. Lowry O.H., Rosebrough N.J., Lewis-Farr A., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
25. Lustman P.J., Griffith L.S., Gavard J.A., and Clouse R.E. Depression in adults with diabetes. Diabetes Care 15 (1992) 1631-1639
26. Maiti P., Singh S.B., Sharma A.K., Muthuraju S., Banerjee P.K., and Ilavazhagan G. Hypobaric hypoxia induces oxidative stress in rat brain. Neurochem. Int. 49 (2006) 709-716
27. McCall A.L. The impact of diabetes on the CNS. Diabetes 41 (1992) 557-570
28. Mongeau R., Biler P., and de Montigny C. The serotonergic and noradrenergic systems of the hippocampus: their interactions and the effects of antidepressant treatments. Brain Res. Rev. 23 3 (1997) 145-195
29. Mooradian A.D. Pathophysiology of central nervous system complications in diabetes mellitus. Clin. Neurosci. 4 6 (1997) 322-326
30. Moreira P.I., Rolo A.P., Sena C., Oliveira C.R., and Santos M.S. Insulin attenuates diabetes-related mitochondrial alterations: a comparative study. Med. Chem. 2 3 (2006) 299-308
31. Nishikawa Y., Edelstein D., Du X.L., Yamagishi S., Matsumurai T., Kaneda Y., Yorek M.A., Beebe D., Oates P.J., Hammes H.P., Giardino I., and Brownlee M. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404 (2000) 787-790
32. Pearce D.A., Atkinson M., and Tagle D.A. Glutamic acid decarboxylase autoimmunity in Batten disease and other disorders. Neurology 63 11 (2004) 2001-2005
33. Przedborski V., Donaldson D.B.S., Jakowec M., Kish J.S., Guttman M., Rosoklija G., and Hays A.P. Brain superoxide dismutase, catalase and glutathione peroxidase activities in amyotrophic lateral sclerosis. Ann. Neurol. 39 (1996) 158-165
34. Porsolt R.D., Le Pichon M., and Jalfre M. Depression: a new model sensitive to antidepressant treatment. Nature 266 (1997) 730-732
35. Rajtar G., Zolkowska D., and Keinrok Z. Effect of diazepam and clonazepam on the function of isolated rat platelet and neutrophils. Intern. Med. J. Exp. Clin. Res. 8 4 (2002) 37-44
36. Reznick A.Z., and Packer L. Free radicals and antioxidants in muscular neurological diseases and disorders. Free Radicals: From Basic Science to Medicine (1993), Birkhäuser Verlag, Basel 425-437
37. Téllez-Zentero J.F., and Cardiel M.H. Risk factors associated whit depression in patients with type 2 diabetes mellitus. Arch. Med. Res. 33 (2002) 53-60
38. Tuzcu M., and Baydas G. Effect of melatonin and vitamin E on diabetes-induced learning and memory impairment in rats. Eur. J. Pharmacol. 537 (2006) 106-110
39. Yoshimoto T., Doi M., Fukai N., Izumiyama H., Wago T., Minami I., Uchimura I., and Hirata Y. Type 1 diabetes mellitus and drug-resistant epilepsy: presence of high titer of anti-glutamic acid decarboxylase autoantibodies in serum and cerebrospinal fluid. Intern. Med. 44 11 (2005) 1174-1177
40. Ziegler D., Ametov A., Barinov A., Dyck P.J., Gurieva I., Low P.A., Munzel U., Yakhno N., Raz I., Novosadova M., Maus J., and Samigullin R. Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial. Diabetes Care 29 11 (2006) 2365-2370